Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 91, Issue 5, Pages 512-519
Publisher
BMJ
Online
2020-03-26
DOI
10.1136/jnnp-2019-322702
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial
- (2019) Greg J. Elder et al. Alzheimers Research & Therapy
- Assessment and Management of Neuropsychiatric Symptoms in Parkinson’s Disease
- (2018) Christoph Mueller et al. CNS DRUGS
- Visual hallucinations in dementia and Parkinson's disease: A qualitative exploration of patient and caregiver experiences
- (2018) Sarah Renouf et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson's disease
- (2017) E. Jaakkola et al. EUROPEAN JOURNAL OF NEUROLOGY
- Accuracy of Clinical Diagnosis of Dementia with Lewy Bodies versus Neuropathology
- (2017) Ragnhild Skogseth et al. JOURNAL OF ALZHEIMERS DISEASE
- Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative
- (2017) Dominic H ffytche et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The psychosis spectrum in Parkinson disease
- (2017) Dominic H. ffytche et al. Nature Reviews Neurology
- Diagnosis and management of dementia with Lewy bodies
- (2017) Ian G. McKeith et al. NEUROLOGY
- Visual Hallucinations in Eye Disease and Lewy Body Disease
- (2016) Prabitha Urwyler et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease
- (2016) Daniel Weintraub et al. JAMA Neurology
- Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations
- (2016) Ahmad A. Khundakar et al. Acta Neuropathologica Communications
- Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses
- (2016) Rajesh R. Tampi et al. Therapeutic Advances in Chronic Disease
- Network localization of neurological symptoms from focal brain lesions
- (2015) Aaron D. Boes et al. BRAIN
- Effect of cataract surgery on cognition, mood, and visual hallucinations in older adults
- (2015) Joanna M. Jefferis et al. JOURNAL OF CATARACT AND REFRACTIVE SURGERY
- On visual hallucinations and cortical networks: a trans-diagnostic review
- (2015) Rowena Carter et al. JOURNAL OF NEUROLOGY
- Negative outcome Charles Bonnet Syndrome
- (2014) Thomas M Cox et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Charles Bonnet syndrome and cognitive impairment: a systematic review
- (2014) Gregor Russell et al. INTERNATIONAL PSYCHOGERIATRICS
- Pharmacological Treatment of Parkinson Disease
- (2014) Barbara S. Connolly et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Successful Treatment of Hallucinations Associated With Sensory Impairment Using Gabapentin
- (2014) Suzanne Holroyd et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Hallucinators find meaning in noises: Pareidolic illusions in dementia with Lewy bodies
- (2014) Kayoko Yokoi et al. NEUROPSYCHOLOGIA
- Caudate dopaminergic denervation and visual hallucinations: Evidence from a 123I-FP-CIT SPECT study
- (2014) Lorenzo Kiferle et al. PARKINSONISM & RELATED DISORDERS
- Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations
- (2014) Sandra A. Jacobson et al. PARKINSONISM & RELATED DISORDERS
- Tricks of the mind: Visual hallucinations as disorders of attention
- (2014) James M. Shine et al. PROGRESS IN NEUROBIOLOGY
- Escitalopram for antipsychotic nonresponsive visual hallucinosis: eight patients suffering from Charles Bonnet syndrome
- (2013) Yoseph Bergman et al. INTERNATIONAL PSYCHOGERIATRICS
- Pedunculopontine Cholinergic Cell Loss in Hallucinating Parkinson Disease Patients but Not in Dementia With Lewy Bodies Patients
- (2013) Dagmar Hyacintha Hepp et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
- (2013) Jeffrey Cummings et al. LANCET
- Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease
- (2013) Jee-Young Lee et al. MOVEMENT DISORDERS
- Clinical and multimodal biomarker correlates of ADNI neuropathological findings
- (2013) Jon B Toledo et al. Acta Neuropathologica Communications
- Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia
- (2012) Yannick Vermeiren et al. Alzheimers & Dementia
- Pareidolias: complex visual illusions in dementia with Lewy bodies
- (2012) Makoto Uchiyama et al. BRAIN
- Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study
- (2012) G. Gibson et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease
- (2012) Bernard Ravina et al. MOVEMENT DISORDERS
- Testing an aetiological model of visual hallucinations in Parkinson's disease
- (2011) D. A. Gallagher et al. BRAIN
- Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease
- (2010) Benedicte Ballanger et al. ARCHIVES OF NEUROLOGY
- Charles Bonnet syndrome improves when treatment is effective in age-related macular degeneration
- (2010) A. Singh et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Yi-Gan San for Treatment of Charles Bonnet Syndrome (Visual Hallucination Due to Vision Loss)
- (2010) Tsuyoshi Miyaoka et al. CLINICAL NEUROPHARMACOLOGY
- Improved Visual Hallucination by Donepezil and Occipital Glucose Metabolism in Dementia with Lewy Bodies: The Osaki-Tajiri Project
- (2010) Masayuki Satoh et al. EUROPEAN NEUROLOGY
- Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
- (2010) Murat Emre et al. LANCET NEUROLOGY
- Increased 5-HT2Areceptors in the temporal cortex of parkinsonian patients with visual hallucinations
- (2010) Philippe Huot et al. MOVEMENT DISORDERS
- A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease
- (2010) Paul Shotbolt Neuropsychiatric Disease and Treatment
- Visual hallucinations in eye disease
- (2009) Dominic H ffytche CURRENT OPINION IN NEUROLOGY
- QUETIAPINE IMPROVES VISUAL HALLUCINATIONS IN PARKINSON DISEASE BUT NOT THROUGH NORMALIZATION OF SLEEP ARCHITECTURE: RESULTS FROM A DOUBLE-BLIND CLINICAL-POLYSOMNOGRAPHY STUDY
- (2009) HUBERT H. FERNANDEZ et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Hallucinations in Parkinson disease
- (2009) Nico J. Diederich et al. Nature Reviews Neurology
- Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis
- (2009) Herbert Y Meltzer et al. NEUROPSYCHOPHARMACOLOGY
- Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease
- (2008) M.E. Kalaitzakis et al. PARKINSONISM & RELATED DISORDERS
- Vision Rehabilitation and Charles Bonnet Syndrome
- (2008) Kara E. Crumbliss et al. Seminars in Ophthalmology
- The hallucinating brain: A review of structural and functional neuroimaging studies of hallucinations
- (2007) Paul Allen et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia
- (2007) A. McKinlay et al. PARKINSONISM & RELATED DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started